Clinical Trials Directory

Trials / Unknown

UnknownNCT02762656

The Effect of Perioperative Lidocaine Intravenous Infusion on Postoperative Recovery After Spine Surgery.

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Sheba Medical Center · Other Government
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to evaluate the effectiveness of perioperative Lidocaine intravenous infusion in reducing postoperative pain for spine surgery patients.

Detailed description

Study design: this study used a prospective, randomized, double-blinded, and placebo-controlled clinical trial. Sixty patients scheduled for a spine surgery will be randomly assigned to two groups. Lidocaine group will receive an intravenous bolus injection of lidocaine 1.5 mg/kg before intubation, followed by 2 mg/kg/h continuous infusion during the operation. Placebo group will receive the same dosage of saline at the same time. Analgesic requirement will be monitored using patient-controlled Analgesia (PCA protocol: demand dose is 2 mg of morphine, lockout 5 min, maximum dose 15 mg per hour). Forty-eight hours after surgery, we will check the morphine consumption in two groups. Quality of recovery after surgery will be assessed using Q0R15 questionnaire.

Conditions

Interventions

TypeNameDescription
DRUGLidocaineLidocaine drip during surgery

Timeline

Start date
2016-06-01
Primary completion
2017-06-01
Completion
2017-08-01
First posted
2016-05-05
Last updated
2016-05-05

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT02762656. Inclusion in this directory is not an endorsement.